Trial Profile
Clinical Trials Insight: 700057387
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2010
Price :
$35
*
At a glance
- Drugs CAL 263 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Rheumatoid arthritis
- Focus Therapeutic Use
- 06 Jul 2010 New trial record